- Home
- SRZN vs DRCT Comparison
SRZN vs DRCT Comparison
Compare SRZN & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- DRCT
- Stock Information
- Founded
- SRZN 2015
- DRCT 2018
- Country
- SRZN United States
- DRCT United States
- Employees
- SRZN N/A
- DRCT N/A
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- DRCT Computer Software: Programming Data Processing
- Sector
- SRZN Health Care
- DRCT Technology
- Exchange
- SRZN Nasdaq
- DRCT Nasdaq
- Market Cap
- SRZN 33.0M
- DRCT 38.7M
- IPO Year
- SRZN N/A
- DRCT 2022
- Fundamental
- Price
- SRZN $11.20
- DRCT $1.06
- Analyst Decision
- SRZN Strong Buy
- DRCT Strong Buy
- Analyst Count
- SRZN 2
- DRCT 3
- Target Price
- SRZN $38.50
- DRCT $21.00
- AVG Volume (30 Days)
- SRZN 28.0K
- DRCT 267.3K
- Earning Date
- SRZN 04-09-2025
- DRCT 03-20-2025
- Dividend Yield
- SRZN N/A
- DRCT N/A
- EPS Growth
- SRZN N/A
- DRCT N/A
- EPS
- SRZN N/A
- DRCT N/A
- Revenue
- SRZN $10,000,000.00
- DRCT $94,216,000.00
- Revenue This Year
- SRZN N/A
- DRCT N/A
- Revenue Next Year
- SRZN N/A
- DRCT $37.23
- P/E Ratio
- SRZN N/A
- DRCT N/A
- Revenue Growth
- SRZN N/A
- DRCT N/A
- 52 Week Low
- SRZN $6.00
- DRCT $0.51
- 52 Week High
- SRZN $18.17
- DRCT $35.88
- Technical
- Relative Strength Index (RSI)
- SRZN 49.20
- DRCT 41.45
- Support Level
- SRZN $11.25
- DRCT $1.10
- Resistance Level
- SRZN $12.55
- DRCT $1.18
- Average True Range (ATR)
- SRZN 0.97
- DRCT 0.08
- MACD
- SRZN 0.11
- DRCT 0.01
- Stochastic Oscillator
- SRZN 55.74
- DRCT 10.00
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.